A diet for dopaminergic neurons?

Journal of Neural Transmission, Supplementa

Volumn , Issue 73, 2009, Pages 317-331

  Di Giovanni, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dietary recommendations; Dopaminergic neurons; Neurodegeneration; Neuroprotection; Parkinson's disease; Prevention

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE A2A RECEPTOR ANTAGONIST; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEINE; CARBOHYDRATE; FATTY ACID; FLAVONOID; FOLIC ACID; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE; MONOUNSATURATED FATTY ACID; NEUROTROPHIN 3; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXIDOPAMINE; POLYPHENOL; POLYUNSATURATED FATTY ACID; PYRIDOXINE; RIBOFLAVIN; SATURATED FATTY ACID; SELENIUM; TRACE ELEMENT; TRANSCRIPTION FACTOR; UBIDECARENONE; DOPAMINE;

AGED; ALCOHOL CONSUMPTION; CALORIC INTAKE; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CLINICAL TRIAL; COFFEE; DAIRY PRODUCT; DIABETES MELLITUS; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DOPAMINERGIC NERVE CELL; FAT INTAKE; HEALTH PROMOTION; HUMAN; INTOXICATION; IRON INTAKE; IRON METABOLISM DISORDER; LIFESTYLE; MACRONUTRIENT; MEAT; MEDITERRANEAN DIET; MINERAL INTAKE; NERVE CELL DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTAKE; RED WINE; REVIEW; RISK FACTOR; TEA; VEGETARIAN DIET; VITAMIN INTAKE; ANIMAL; ARTICLE; DIET; DIET THERAPY; DISEASE MODEL; METABOLISM; NERVE CELL; NUTRITION; PHYSIOLOGY;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; NEURONS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PARKINSON DISEASE;

EID: 77952316063     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-92660-4-27     Document Type: Review

References (166)

1. Abbott RD, Ross GW, White LR, Sanderson WT, Burchfiel CM, Kashon M, Sharp DS, Masaki KH, Curb JD, Petrovitch H (2003) Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. J Neurol 250 Suppl: III30-III39
2. Aguiar LM, Nobre HV Jr, Macedo DS, Oliveira AA, Freitas RM, Vasconcelos SM, Cunha GM, Sousa FC, Viana GS (2006) Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacol Biochem Behav 84:415-419
3. Aguilar MV, Jiménez-Jiménez FJ, Molina JA, Meseguer I, Mateos-Vega CJ, González-Muñoz MJ, de Bustos F, Gómez-Escalonilla C, Ort-Pareja M, Zurdo M, Martínez-Para MC (1998) Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease. J Neural Transm 105:1245-1251
4. Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE (2000) Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 60:409-470
5. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD (1999) Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord 14:21-27
6. Annanmaki T, Muuronen A, Murros K (2007) Low plasma uric acid level in Parkinson's disease. Mov Disord 22:1133-1137
7. Armentero MT, Levandis G, Bramanti P, Nappi G, Blandini F (2008) Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease. Exp Neurol 212(2):548-551
8. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC (2001) Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50:56-63
9. Beal MF, Matthews RT, Tieleman A, Shults CW (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1, 2, 3, tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res 783:109-114
10. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455
11. Blanchet J, Longpré F, Bureau G, Morissette M, DiPaolo T, Bronchti G, Martinoli MG (2008) Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 32:1243-1250
12. Bourre JM (2006a) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 10:377-385
13. Bourre JM (2006b) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386-399
14. Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J 22:1213-1225
15. Britten P, Marcoe K, Yamini S, Davis C (2006) Development of food intake patterns for the MyPyramid food guidance system. J Nutr Educ Behav 38 Suppl: S78-S92
16. Burgener SC, Buettner L, Coen Buckwalter K, Beattie E, Bossen AL, Fick DM, Fitzsimmons S, Kolanowski A, Richeson NE, Rose K, Schreiner A, Pringle Specht JK, Testad I, Yu F, McKenzie S (2008) Evidence supporting nutritional interventions for persons in early stage Alzheimer's disease (AD). J Nutr Health Aging 12:18-21
17. Cadet JL (1986) The potential use of vitamin E and selenium in Parkinsonism. Med Hypotheses 20(1):87-94
18. Cadet JL, Katz M, Jackson-Lewis V, Fahn S (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 476:10-15
19. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33(12):2444-2471
20. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W (1994) Manganism and idiopathic Parkinsonism: similarities and differences. Neurology 44(9):1583-1586
21. Cansev M, Ulus IH, Wang L, Maher TJ, Wurtman RJ (2008) Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. Neurosci Res 62(3):206-209
22. Cersosimo MG, Koller WC (2006) The diagnosis of manganeseinduced Parkinsonism. Neurotoxicology 27(3):340-346
23. Chan DK, Woo J, Ho SC, Pang CP, Law LK, Ng PW, Hung WT, Kwok T, Hui E, Orr K, Leung MF, Kay R (1998) Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 65(5):781-784
24. Chao J, Yu MS, Ho YS, Wang M, Chang RC (2008) Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med 45:1019-1026
25. Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK (2006) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol Dis 22:421-434
26. Chan DK, Woo J, Ho SC, Pang CP, Law LK, Ng PW, Hung WT, Kwok T, Hui E, Orr K, Leung MF, Kay R (1998) Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 65(5):781-784
27. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155:732-738
28. Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N Jr, Schwarzschild MA (2001) Neuroprotection by caffeine and A (2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21: RC143
29. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A (2002) Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol 52(6):793-801
30. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 157:1007-1014
31. Chen H, O'Reilly E, McCullough ML, Rodriguez C, Schwarzschild MA, Calle EE, Thun MJ, Ascherio A (2007) Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol 165:998-1006
32. Chen LW, Wang YQ, Wei LC, Shi M, Chan YS (2007) Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS Neurol Disord Drug Targets 6:273-281
33. Chen X, Lan X, Roche I, Liu R, Geiger JD (2008) Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem 107(4):1147-1157
34. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J (2005) Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81:341-354
35. Coughlin SS, Pincus JH, Karstaedt P (1992) An international comparison of dietary protein consumption and mortality from Parkinson's disease. J Neurol 239(4):236-237
36. Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 12:3871-3875
37. Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI, Dexter DT (2007) Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease. J Am Coll Nutr 26:341-349
38. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P (1986) Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 235:747-754
39. Davies KN, King D, Davies H (1994) A study of the nutritional status of elderly patients with Parkinson's disease. Age Ageing 23(2):142-145
40. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM (1996) Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol 144:480-484
41. de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM (2005a) Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 64:2040-2045
42. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2005b) Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 58:797-800
43. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2006a) Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 164:998-1002
44. de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM (2006b) Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 67:315-318
45. de Rijk MC, Breteler MM, den Breeijen JH, Launer LJ, Grobbee DE, van der Meche FG, Hofman A (1997) Dietary antioxidants and Parkinson disease. The Rotterdam study. Arch Neurol 54:762-765
46. Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM (2001) Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology 20:7-15
47. Di Giovanni G (2007) The Basal Ganglia Pathophysiology: Recent Advances. Transworld Research Network, Kerala, India
48. Di Giovanni G (2008) Will it ever become possible to prevent dopaminergic neuronal degeneration? CNS Neurol Disord Drug Targets 7(1):28-44
49. Di Matteo V, Pierucci M, Di Giovanni G, Dragani LK, Murzilli S, Poggi A, Esposito E (2009) Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons. J Neural Transm Suppl 73:
50. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384-386
51. Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G (2008) Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 31(10):2003-2005
52. Duan W, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res 57:195-206
53. Etminan M, Gill SS, Samii A (2005) Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol 4:362-365
54. Fall PA, Fredrikson M, Axelson O, Granerus AK (1999) Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 14:28-37
55. Farooqui AA, Horrocks LA (1998) Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol Neurobiol 18:599-608
56. Finkelstein MM, Jerrett M (2007) A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environ Res 104(3):420-432
57. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133
58. Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, Ascherio A (2007) Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 86:1486-1494
59. Gao X, Chen H, Choi HK, Curhan G, Schwarzschild MA, Ascherio A (2008) Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol 167:831-838
60. Gebicke-Haerter PJ (2001) Microglia in neurodegeneration: molecular aspects. Microsc Res Tech 54:47-58
61. Gélinas S, Martinoli MG (2002) Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J Neurosci Res 70:90-96
62. Gorell JM (1999) Occupational exposure to manganese, copper, lead, iron, mercury, and zinc and the risk of Parkinson's disease. Neurotoxicology 20:239-247
63. Guo S, Bezard E, Zhao B (2005) Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39:682-695
64. Guo S, Yan J, Yang T, Yang X, Bezard E, Zhao B (2007) Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry 62:1353-1362
65. Hartmann A, Hirsch EC (2001) Parkinson's disease. The apoptosis hypothesis revisited. Adv Neurol 86:143-153
66. Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 30:563-571
67. Hellenbrand W, Boeing H, Robra BP, Seidler A, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G (1996a) Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 47(3):644-650
68. Hellenbrand W, Seidler A, Boeing H, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G (1996b) Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 47(3):636-643
69. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284
70. Hertzman C, Wiens M, Bowering D, Snow B, Calne D (1990) Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 17:349-355
71. Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol: S115-S120
72. Hornykiewics O (1988) Neurochemical pathology and aetiology of Parkinson's disease: basic facts and hypothetical possibilities. Mt Sinai J Med 55:11-20
73. Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J (2006) Body mass index and the risk of Parkinson disease. Neurology 67:1955-1959
74. Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J (2007a) Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 22:2242-2248
75. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J (2007b) Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30:842-847
76. Huang X, Chen H, Miller WC, Mailman RB, Woodard JL, Chen PC, Xiang D, Murrow RW, Wang YZ, Poole C (2007) Lower lowdensity lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord 22:377-381
77. Ikeda K, Kashihara H, Tamura M, Kano O, Iwamoto K, Iwasaki Y (2007) Body mass index and the risk of Parkinson disease. Neurology 68:2156
78. Isobe C, Murata T, Sato C, Terayama Y (2007) Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease. J Clin Neurosci 14:340-343
79. Itoh N, Masuo Y, Yoshida Y, Cynshi O, Jishage K, Niki E (2006) gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain. Neurosci Lett 403:136-140
80. Jellinger KA (2000) Cell death mechanisms in Parkinson's disease. J Neural Transm 107:1-29
81. Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson's disease. Neurology: S24-S36
82. Jimenez-Jimenez FJ, Molina JA, Arrieta FJ, Aguilar MV, Cabrera-Valdivia F, Vaquez A, Jorge-Santamaria A, Seijas V, Femhdez-Calle P, Martinez-Para MC (1995) Decreased serum selenium concentrations in patients with Parkinson's disease. Euro J Neurol 2:111-114
83. Jimenez-Jimenez FJ, Molina JA, de Bustos F, Garcia-Redondo A, Gomez-Escalonilla C, Martinez-Salio A, Berbel A, Camacho A, Zurdo M, Barcenilla B, Enriquez de Salamanca R, Arenas J (2000) Serum levels of coenzyme Q10 in patients with Parkinson's disease. J Neural Transm 107:177-181
84. Joghataie MT, Roghani M, Negahdar F, Hashemi L (2004) Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence. Parkinsonism Relat Disord 10:465-468
85. Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL (1999) Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 28:1102-1109
86. Julien C, Berthiaume L, Hadj-Tahar A, Rajput AH, Bédard PJ, Di Paolo T, Julien P, Calon F (2006) Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 48:404-414
87. Kandinov B, Giladi N, Korczyn AD (2007) The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. Parkinsonism Relat Disord 13:243-245
88. Kelsey JE, Langelier NA, Oriel BS, Reedy C (2009) The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A (2A) and A (1) antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. Psychopharmacology (Berl) 201:529-539
89. Kim HC, Jhoo WK, Choi DY, Im DH, Shin EJ, Suh JH, Floyd RA, Bing G (1999) Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res 851:76-86
90. Lai BC, Marion SA, Teschke K, Tsui JK (2002) Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat Disord 8:297-309
91. Lau FC, Shukitt-Hale B, Joseph JA (2007) Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell Biochem 42:299-318
92. Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, Commenges D (1998) Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol 148:298-306
93. Levenson CW, Rich NJ (2007) Eat less, live longer? New insights into the role of caloric restriction in the brain. Nutr Rev 65(9):412-415
94. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78:1073-1082
95. Levites Y, Amit T, Youdim MB, Mandel S (2002a) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277:30574-30580
96. Levites Y, Youdim MB, Maor G, Mandel S (2002b) Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21-29
97. Li R, Peng N, Du F, Li XP, Le WD (2006) Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine- induced neurotoxicity by inhibiting microglial cell activation. Nan Fang Yi Ke Da Xue Xue Bao 26:376-380
98. Lieberman A, Lyons K, Levine J, Myerburg R (2005) Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease. Parkinsonism Relat Disord 11:81-84
99. Logroscino G, Mayeux R (1997) Diet and Parkinson's disease. Neurology 49:310-311
100. Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R (1996) Dietary lipids and antioxidant in Parkinson's disease: a populationbased, case-control study. Ann Neurol 39:89-94
101. Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, Lojacono N, Cote L, Mayeux R (1998) Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord 13 Suppl 1:13-16
102. Logroscino G, Gao X, Chen H, Wing A, Ascherio A (2008) Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol 168(12):1381-1388
103. Mahfouz MM, Kummerow FA (2004) Vitamin C or Vitamin B6 supplementation prevent the oxidative stress and decrease of prostacyclin generation in homocysteinemic rats. Int J Biochem Cell Biol 36:1919-1932
104. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747
105. Martin B, Mattson MP, Maudsley S (2006) Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev 3:332-353
106. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, Grondin R, Roth GS, Mattison J, Lane MA, Carson RE, Cohen RM, Mouton PR, Quigley C, Mattson MP, Ingram DK (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci USA 101(52):18171-18176
107. Matsubara T, Azuma T, Yoshida S, Yamagami T (1991) Serum coenzyme Q-10 level in Parkinson syndrome. In: Folkers K, Littarru P, Yamagami T (eds) Biomedical and clinical aspects of Coenzyme Q. Elsevier, Amsterdam, pp 159-166
108. Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95:8892-8897
109. Mattson MP (2003) Will caloric restriction and folate protect against AD and PD? Neurology 60(4):690-695
110. Mattson MP (2008) Dietary factors, hormesis and health. Ageing Res Rev 7(1):43-48
111. McCarty MF (2001) Does a vegan diet reduce risk for Parkinson's disease? Med Hypotheses 57:318-323
112. Mizuno Y, Matuda S, Yoshino H, Mori H, Hattori N, Ikebe S (1994) An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol 35:204-210
113. Nair VD (2006) Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Apoptosis 11:955-966
114. Naughton DP, Petróczi A (2008) Heavy metal ions in wines: metaanalysis of target hazard quotients reveal health risks. Chem Cent J 2:22
115. Nie G, Cao Y, Zhao B (2002) Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep 7:171-177
116. Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/ probenecid model of Parkinson's disease. Neuroscience 140:67-76
117. Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M (1998) Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J Am Geriatr Soc 46:1-7
118. Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A (2007) Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 73:550-560
119. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, Breteler MB (1997) Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153:185-192
120. Oztas E, Kalda A, Xu K, Irrizary MC, Schwarzschild MA, Chen JF (2002) Caffeine attenuates MPTP-induced loss of dopaminergic neurons in substantia nigra in mice. Soc Neurosci A487.6
121. Park M, Ross GW, Petrovitch H, White LR, Masaki KH, Nelson JS, Tanner CM, Curb JD, Blanchette PL, Abbott RD (2005) Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology 64:1047-1051
122. Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early PD. N Engl J Med 328:176-183
123. Pasinetti GM, Eberstein JA (2008) Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem 106(4):1503-1514
124. Perl DP, Olanow CW (2007) The neuropathology of manganeseinduced Parkinsonism. J Neuropathol Exp Neurol 66(8):675-682
125. Perumal AS, Gopal VB, Tordzro WK, Cooper TB, Cadet JL (1992) Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bull 29:699-701
126. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H (2003) Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60:1761-1766
127. Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H (2008) Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord 23:88-95
128. Prolla TA, Mattson MP (2001) Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci: S21-S31
129. Racette BA, Tabbal SD, Jennings D, Good BA, Perlmutter JS, Evanoff B (2005) Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 64:230-235
130. Ragonese P, Salemi G, Morgante L, Aridon P, Epifanio A, Buffa D, Scoppa F, Savettieri G (2003) A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology 22:297-304
131. Ragonese P, D'Amelio M, Callari G, Di Benedetto N, Palmeri B, Mazzola MA, Terruso V, Salemi G, Savettieri G, Aridon P (2008) Body mass index does not change before Parkinson's disease onset. Eur J Neurol 15(9):965-968
132. Rajeswari A, Sabesan M (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16:96-99
133. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526
134. Ristow M (2004) Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 82:510-529
135. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674-2679
136. Roth G, Lane M, Ingram D, Mattson J (2002) Biomarkers of caloric restriction may predict longevity in humans. Science 297:811
137. Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A, Breteler MM (2002) Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359:281-286
138. Sandyk R (1993) The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69:125-130
139. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287-306
140. Schapira AH (2005) Present and future drug treatment for Parkinson's disease. J Neurol Neurosurg Psychiatry 76:1472-1478
141. Scheele C, Nielsen AR, Walden TB, Sewell DA, Fischer CP, Brogan RJ, Petrovic N, Larsson O, Tesch PA, Wennmalm K, Hutchinson DS, Cannon B, Wahlestedt C, Pedersen BK, Timmons JA (2007) Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J 21(13):3653-3665
142. Semchuk KM, Love EJ, Lee RG (1993) Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 43:1173-1180
143. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59:1541-1550
144. Sian J, Gerlach M, Youdim MB, Riederer P (1999) Parkinson's disease: a major hypokinetic basal ganglia disorder. J Neural Transm 106:443-476
145. Sies H, Stahl W, Sundquist AR (1992) Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann NY Acad Sci 669:7-20
146. Simon KC, Chen H, Schwarzschild M, Ascherio A (2007) Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 69:1688-1695
147. Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC, NET-D Investigators (2008) Caffeine and progression of Parkinson disease. Clin Neuropharmacol 31:189-196
148. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008) Adherence to Mediterranean diet and health status: meta-analysis. BMJ 337: a1344
149. Sriram K, Benkovic SA, Miller DB, O'Callaghan JP (2002) Obesity exacerbates chemically induced neurodegeneration. Neuroscience 115(4):1335-1346
150. Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Muller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H (2007) Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q (10) in Parkinson disease. Arch Neurol 64:938-944
151. Suganuma H, Hirano T, Arimoto Y, Inakuma T (2002) Effect of tomato intake on striatal monoamine level in a mouse model of experimental Parkinson's disease. J Nutr Sci Vitaminol 48(3):251-254
152. Tan EK, Tan C, Fook-Chong SM, Lum SY, Chai A, Chung H, Shen H, Zhao Y, Teoh ML, Yih Y, Pavanni R, Chandran VR, Wong MC (2003) Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci 216:163-167
153. Tan EK, Chua E, Fook-Chong SM, Teo YY, Yuen Y, Tan L, Zhao Y (2007) Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogenet Genomics 17:1001-1005
154. Tan LC, Koh WP, Yuan JM, Wang R, Au WL, Tan JH, Tan EK, Yu MC (2008) Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 167:553-560
155. Tanner CM, Langston JW (1990) Do environmental toxins cause Parkinson's disease? A critical review. Neurology 40 Suppl 3: S17-S30
156. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160
157. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM (2005) Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 19(6):659-661
158. Weindruch R, Walford RL, Fligiel S, Guthrie D (1986) The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr 4:641-654
159. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D (1995) Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 61 Suppl 6:1402S-1406S
160. Willett WC (2008) Overview and perspective in human nutrition. Asia Pac J Clin Nutr 17 Suppl 1:1-4
161. World Health Organ (2003) Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 916: i-viii
162. World Resource Institute (2003) Countries by coffee consumption per capita. http://earthtrends.wri.org/searchable-db/index.php?theme=6&variable- ID=294&action=select-countries
163. Xu K, Xu Y, Brown-Jermyn D, Chen JF, Ascherio A, Dluzen DE, Schwarzschild MA (2006) Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. J Neurosci 26:535-541
164. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H (1986) Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 70:273-278
165. Yurek DM, Sladek JR Jr (1990) Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci 13:415-440
166. Zhang SM, Hernan MA, Chen H, Spiegelman D, Willett WC, Ascherio A (2002) Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 59:1161-1169